PULSE BIOSCIENCES INC (PLSE) Stock News

USA - Nasdaq - NASDAQ:PLSE - US74587B1017 - Common Stock

14.38 USD

+0.12 (+0.84%)

Last: 12/18/2025, 4:30:00 PM

14.38 USD

0 (0%)

After Hours: 12/18/2025, 4:30:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

PLSE Latest News, Press Relases and Analysis

All

Press Releases

14 hours ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation

8 days ago - By: Zacks Investment Research - Mentions: ISRG VCYT AORT

PLSE Starts Research Work on nPulse Technology to Treat Thyroid Tumor

10 days ago - By: Pulse Biosciences, Inc.

Pulse Biosciences, Inc. Announces Initiation of Research Collaboration for the Treatment of Benign and Malignant Thyroid Tumors with nPulse™ Technology

a month ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

a month ago - By: Benzinga - Mentions: TECH INSE GEF SKYT ...

Earnings Scheduled For November 5, 2025

a month ago - By: Pulse Biosciences, Inc.

Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences

a month ago - By: The Motley Fool

Pulse Biosciences (PLSE) Earnings Transcript

a month ago - By: Zacks Investment Research - Mentions: TFX

Pulse Biosciences, Inc (PLSE) Reports Q3 Loss, Lags Revenue Estimates

a month ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results

2 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study

2 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025

2 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: Zacks Investment Research - Mentions: EW MASI NDRA

Pulse Biosciences Unveils Promising First-in-Human Data for nPulse

2 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting

7 months ago - By: Benzinga - Mentions: MSC ELUT ACIW JYNT ...

Earnings Scheduled For May 8, 2025

2 months ago - By: Pulse Biosciences

Pulse Biosciences Announces Clinical Data Highlighting its nPulse™ Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting

3 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences’ nPulse™ Technology to be Featured at the American Thyroid Association 2025 Annual Meeting

3 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces FDA IDE Approval to Initiate its nsPFA Cardiac Surgery System Study for the Treatment of Atrial Fibrillation

4 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

4 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces First Successful Procedures in PRECISE Benign Thyroid Nodule (BTN) Study

4 months ago - By: Zacks Investment Research - Mentions: BSX WST MEDP

PLSE Shares Rise on First-in-Human Data for Thyroid Nodule Treatment

4 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces Publication of First-In-Human Data for Treatment of Benign Thyroid Nodules in the Journal Thyroid

4 months ago - By: The Motley Fool

Pulse Biosciences Cash Jumps in Q2

4 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Reports Business Updates and Second Quarter 2025 Financial Results

5 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences To Present at the 45th Canaccord Genuity Annual Growth Conference

5 months ago - By: Pulse Biosciences

Pulse Biosciences Schedules Second Quarter 2025 Business Updates and Financial Results Conference Call for August 12, 2025

5 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

7 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

7 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results

8 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference

8 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting

8 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)